Seizure pathophysiology

Jump to navigation Jump to search

Seizure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seizure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seizure pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seizure pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seizure pathophysiology

CDC on Seizure pathophysiology

Seizure pathophysiology in the news

Blogs on Seizure pathophysiology

Directions to Hospitals Treating Seizure

Risk calculators and risk factors for Seizure pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

Normally, seizures do not occur because the membrane stability of neurons is maintained, and the discharges that lead to seizures are prevented from transferring. In a normal brain, some circumstances can provoke seizures, such as: hyponatremia, drug withdrawal, and hypoglycemia. Abnormalities in different parts of the nervous system may cause seizure, such as: brain regions, cells, ions, networks, and receptors. The imbalance of excessive excitation and reduced inhibition that causes and keeps the seizure going on. Glutamate is the most common excitation neurotransmitter and affects by the N-methyl-D-aspartate (NMDA) receptor. However, NMDA antagonist drugs have not been clinically successful. Gamma-aminobutyric acid (GABA) is the most common inhibition neurotransmitter. GABA inhibits excess excitation of the neurons by activating the GABAA receptor. Increasing the inhibition of GABA (even if the inhibition is not damaged) may be helpful in a seizure, since it may overwhelm the excess excitation of the seizure. Examples of GABA-enhancing drugs are benzodiazepines, barbiturates, propofol, and some anesthetics. However, these drugs are not suitable for long term therapy since patients usually become tolerant to their effect.

Pathophysiology

Normally, seizures do not happen because the membrane stability of neurons is maintained, and the discharges that lead to seizures are prevented from transferring.[1]

In a normal brain, some circumstances can provoke seizures, such as:[1]

Abnormalities in different parts of the nervous system may cause seizure, such as:[1]

For example:

Pathophysiology of generalized tonic-clonic seizures

  • Generalized tonic-clonic seizure initiates with an excessive excitation of neurons, leading to synchronous discharges of more neurons, and affects a part of the brain that causes the clinical signs and symptoms of the seizure.
  • The imbalance of excessive excitation and reduced inhibition that causes and keeps the seizure going on.[6]

N-methyl-D-aspartate (NMDA) Receptor

Gamma aminobutyric acid (GABA) Receptor

References

  1. 1.0 1.1 1.2 Huff JS, Fountain NB (2011). "Pathophysiology and definitions of seizures and status epilepticus". Emerg Med Clin North Am. 29 (1): 1–13. doi:10.1016/j.emc.2010.08.001. PMID 21109098.
  2. Mulley JC, Scheffer IE, Petrou S, Berkovic SF (2003). "Channelopathies as a genetic cause of epilepsy". Curr Opin Neurol. 16 (2): 171–6. doi:10.1097/01.wco.0000063767.15877.c7. PMID 12644745.
  3. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR; et al. (1995). "A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy". Nat Genet. 11 (2): 201–3. doi:10.1038/ng1095-201. PMID 7550350.
  4. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L (1989). "Mossy fiber synaptic reorganization in the epileptic human temporal lobe". Ann Neurol. 26 (3): 321–30. doi:10.1002/ana.410260303. PMID 2508534.
  5. Andermann F (2000). "Cortical dysplasias and epilepsy: a review of the architectonic, clinical, and seizure patterns". Adv Neurol. 84: 479–96. PMID 11091890.
  6. 6.0 6.1 Fountain NB, Lothman EW (1995). "Pathophysiology of status epilepticus". J Clin Neurophysiol. 12 (4): 326–42. PMID 7560021.